LKC Technologies Announces Acquisition by AMETEK, Strengthening Long-Term Commitment to Eye Care Professionals
GERMANTOWN, MARYLAND, USA, February 13, 2026 – LKC Technologies, a leader in functional retinal testing using electroretinography (ERG), announces that it has been acquired by AMETEK, Inc. (NYSE: AME), a global provider of industrial technology solutions. The acquisition reflects LKC’s continued growth, strong market adoption, and long-term commitment to supporting eye care professionals worldwide.
Over the past several years, LKC Technologies has experienced strong, sustained growth driven by the trust and engagement of eye care professionals who rely on the RETeval® ERG device. Clinicians across the country and around the world have embraced this handheld solution because it delivers meaningful clinical value and integrates seamlessly into real-world practice.
“This acquisition reflects the strength of our business, the impact of our innovation, and the confidence the market has placed in our technology,” said Dina Dubey, Chief Executive Officer of LKC Technologies. “Becoming part of AMETEK is a powerful validation of what our customers and partners have already recognized—LKC is building something lasting. We are joining a financially strong, publicly traded global organization that has been listed on the New York Stock Exchange for more than 95 years and that includes Reichert, one of the most respected legacy brands in eye care. This partnership strengthens our ability to invest, innovate, and expand, while maintaining the personalized support and clinical focus our customers have come to expect.”
“We are excited to welcome LKC Technologies to AMETEK,” said David A. Zapico, AMETEK Chairman and Chief Executive Officer. “LKC Technologies is an excellent strategic fit, providing attractive market expansion opportunities and creating a broader ophthalmic product portfolio. We look forward to leveraging our respective design and engineering capabilities to further advance patient eye healthcare together.”
About LKC Technologies. LKC Technologies® is a 35-year veteran of visual electrophysiology (ERG). The RETeval ERG is the only handheld, FDA-cleared device for ERG testing on dilated and un-dilated patients. It was designed to streamline clinic operations and simplify testing for staff and patients alike. It is supported by more than 250 peer-reviewed publications and is used in optometry, ophthalmology, and research settings.
About AMETEK. AMETEK (NYSE: AME) is a leading global provider of industrial technology solutions serving a diverse set of attractive niche markets with annual sales of approximately $7.5 billion. The AMETEK Growth Model integrates the Four Growth Strategies – Operational Excellence, Technology Innovation, Global and Market Expansion, and Strategic Acquisitions – with a disciplined focus on cash generation and capital deployment. AMETEK’s objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. Founded in 1930, AMETEK has been listed on the NYSE for over 95 years and is a component of the S&P 500. For more information, visit www.ametek.com.
###
Contact:
Olga Fabera
Senior Marketing Manager